Premedication for irinotecan.
Zampa
G
G
Magnolfi
E
E
Borgomastro
A
A
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D000077146:Irinotecan; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D011292:Premedication; D012601:Scopolamine / Q000627:therapeutic use*; D059004:Topoisomerase I Inhibitors
D000972:Antineoplastic Agents, Phytogenic; D018727:Muscarinic Antagonists; D059004:Topoisomerase I Inhibitors; D000077146:Irinotecan; D012601:Scopolamine; D002166:Camptothecin